This is a bone condition where fibrous tissue replaces normal bone. It can cause pain, make bones weaker, and lead to deformities over time. It can affect just one bone or multiple bones.
Every report comes from a Lived member, sent anonymously.
Have you tried Aredia (Pamidronate) for Fibrous Dysplasia of Bone?
Fibrous dysplasia of bone is a noncancerous condition in which areas of normal bone are replaced by fibrous, scar-like tissue mixed with soft, poorly formed bone. These patches, called lesions, can expand a bone and make it weaker than usual. Depending on where they are, they may cause bone pain, a bowed or misshapen limb, a difference in leg length, a visible change in the shape of the face or skull, or a bone that breaks with little force. Fibrous dysplasia can involve a single bone (monostotic), which is the most common form, or several bones (polyostotic). The skull and face, the thighbone and shinbone, the ribs and the pelvis are common sites. The range is very wide: some people learn they have a small lesion only because an X-ray taken for another reason shows it, while others have many affected bones and repeated fractures. Fibrous dysplasia sometimes occurs as part of McCune-Albright syndrome, which adds light-brown skin patches with jagged edges (café-au-lait spots) and overactive hormone glands, such as puberty starting unusually early.
Fibrous dysplasia is caused by a change in a gene called GNAS (which controls a signaling protein inside cells) that happens in a single cell early in development, after conception. Only the cells descended from that cell carry the change, which is why the condition can affect one bone, several bones, or bone together with skin and hormone glands. In bone, the change keeps a growth signal switched on, so the cells that should build normal bone produce fibrous tissue instead. Because the gene change is not present in egg or sperm cells, fibrous dysplasia is not inherited from parents and is not passed on to children. There are no known exposures or behaviors that cause it. Some factors can make existing bone disease behave worse. Lesions can release a hormone called fibroblast growth factor 23 (FGF23) that makes the kidneys waste phosphate, a mineral bones need, and low phosphate is linked with more fractures. In McCune-Albright syndrome, excess growth hormone or an overactive thyroid can also aggravate the bone disease.
Fibrous dysplasia is often recognized on imaging. On an X-ray or a computed tomography (CT) scan (a series of X-ray images combined into detailed cross-sections), lesions typically have a hazy, ground-glass look, can widen the bone and thin its outer shell, and may contain cyst-like areas. CT gives the most detail, especially for the skull, face, spine and pelvis. When the pattern is typical, a biopsy is not needed. A biopsy, in which a small sample of the lesion is removed and examined, is used when the diagnosis is uncertain, when a single lesion could be something else (such as a bone cyst or another benign bone tumor), or when cancer is a concern. The sample can also be tested for the GNAS change. A blood test for the gene change supports the diagnosis if it is positive, but a negative result does not rule fibrous dysplasia out, because the change is usually found only in affected tissue. Once fibrous dysplasia is found, the next step is mapping its extent. A whole-body bone scan or similar imaging shows whether other bones are involved. Blood tests check calcium, vitamin D and alkaline phosphatase (ALP), an enzyme that rises when bone is being remodeled quickly. Fasting blood and urine phosphate tests show whether the kidneys are losing phosphate, which matters because low phosphate predicts future fractures. Doctors also look for the skin spots and hormone problems of McCune-Albright syndrome, such as early puberty, an overactive thyroid or excess growth hormone, since treating them helps protect the bones.
There is no cure for fibrous dysplasia, and no medicine is approved by the US Food and Drug Administration (FDA) specifically for it. Treatment aims to control pain, keep bones strong and well aligned, and manage problems that make the bone disease worse. A small lesion that causes no symptoms often needs nothing more than monitoring. Surgery is the main option for a bone that has broken, is at high risk of breaking, or is becoming badly bowed, such as the shepherd's crook bend that can develop at the top of the thighbone. Surgeons usually stabilize the weakened bone with a metal rod placed inside it, sometimes after cutting and realigning the bone (an osteotomy). Simply scraping out a lesion and packing it with bone graft generally does not work and can cause complications. Lesions have a rich blood supply, so operations can involve significant bleeding, and a deformity can return, so children in particular may need further surgery as they grow. Physical therapy and mobility aids help recovery. For skull and facial fibrous dysplasia, careful watching is often the best choice because the long-term results of surgery are hard to predict. Surgery is considered when a lesion threatens vision, hearing or the nasal airway, or causes severe pain or disfigurement, and it is planned by an experienced craniofacial team. Removing bone around the optic nerve purely as a precaution is not recommended. Bone pain is treated with ordinary pain relievers, physical therapy and, when needed, a specialist pain team. For persistent bone pain, intravenous bisphosphonates (pamidronate or zoledronic acid), medicines that slow the breakdown of bone, relieve pain in some people. They do not shrink lesions, and bisphosphonate tablets such as alendronate have not been shown to help fibrous dysplasia pain. Before starting, low phosphate and vitamin D should be corrected, and a dental check is advised because these medicines carry a small risk of jaw bone damage (osteonecrosis of the jaw). Denosumab, an injectable bone medicine, is being studied but is used only at specialist centers, because stopping it can cause a rebound surge in bone breakdown and very high calcium levels. Low phosphate is treated with calcitriol, an active form of vitamin D, sometimes with phosphate supplements for a time, along with regular blood and urine checks. Enough calcium and vitamin D, not smoking and limiting alcohol support bone health. When fibrous dysplasia is part of McCune-Albright syndrome, treating the hormone problems is part of protecting the skeleton.
The course varies widely. Many people with a single small lesion have few or no symptoms and need only occasional checks. People with many affected bones are more likely to have pain, fractures and deformity, and may need several operations over their lifetime. Pain is common overall, reported by roughly half to two-thirds of people with fibrous dysplasia, and it is more common in adults than in children. Fibrous dysplasia usually begins in childhood. The lesions a person will have are generally all present by about age 15, and fractures are most frequent between ages 6 and 10, becoming less frequent afterward. Follow-up depends on where the lesions are: people with lesions at the base of the skull usually have a hearing test every year, children with facial or skull lesions have periodic CT scans, and adults are scanned mainly when symptoms change. Ordinary dental and orthodontic care is safe and does not make jaw or facial lesions worse, although teeth can move faster during orthodontic treatment and are more likely to drift back afterward. Lesions almost always stay benign. Cancer arising in a lesion is very rare, but radiation to an affected bone raises that risk, so radiation treatment near lesions is avoided whenever possible. Higher rates of breast and prostate cancer have been observed in people with fibrous dysplasia, so keeping up with routine cancer screening matters. Because the condition is rare, care often works best when coordinated through a center with experience in fibrous dysplasia, bringing together an endocrinologist, an orthopedic surgeon and, when needed, craniofacial, pain and physical therapy specialists. Patient groups can offer practical information and support.
See a doctor about a hard bony lump, a bone that keeps aching, a limp, a limb that looks bowed or a change in the shape of the face, or if an X-ray has shown a possible lesion. In a child, signs of early puberty (such as breast development or vaginal bleeding before age 8) or café-au-lait spots with jagged edges are reasons to ask about McCune-Albright syndrome. If you already have fibrous dysplasia, contact your care team promptly about bone pain that wakes you at night or comes on when you stand or walk on the affected limb, since it can signal a bone close to breaking, and about a lesion that seems to be growing quickly or pain that changes in character. With skull or facial lesions, any change in vision, eye position, hearing or nasal breathing needs urgent assessment by an experienced team. Sudden severe pain in an affected bone, especially after a fall or if you cannot put weight on the limb, may mean a fracture and should be assessed the same day.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Fibrous Dysplasia of Bone is like, what's helped you, or ask the community a question.